Peptide Reference

Mod GRF 1-29

Modified Growth Hormone Releasing Factor 1-29

A modified version of GHRH (sermorelin) with enhanced stability. Also known as CJC-1295 without DAC.

Status

research

Category

growth hormone

Typical cost

$40-80/vial (2mg)

Mechanism

Stimulates growth hormone release from pituitary. Shorter half-life than CJC-1295 with DAC requires multiple daily dosing but more closely mimics natural GH pulsatility.

Potential benefits

  • Increased growth hormone
  • More natural pulsatility
  • Fat loss
  • Muscle preservation

Reported side effects

  • Water retention
  • Injection site reactions
  • Numbness/tingling

Common dosing references

subcutaneous

100-300mcg · 1-3x daily

8-12 weeks

Research notes

Mod GRF and GH stimulation

2005

Demonstrated effective GH stimulation with pulsatile pattern

Regulatory and sourcing notes

Research chemical only. Not FDA-approved.

Research peptide. Same as CJC-1295 without DAC. More natural GH pattern but requires frequent dosing.

Find peptide-aware clinics

Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.

Search Local Clinics

Related peptides

CJC-1295IpamorelinSermorelin